These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 20123937)
21. [Mechanism of action of antidepressants and therapeutic perspectives]. Bourin M; David DJ; Jolliet P; Gardier A Therapie; 2002; 57(4):385-96. PubMed ID: 12422559 [TBL] [Abstract][Full Text] [Related]
22. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507 [TBL] [Abstract][Full Text] [Related]
23. Serotonin and psychiatric disorders. A key to new therapeutic approaches. Costall B; Naylor RJ Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395 [TBL] [Abstract][Full Text] [Related]
24. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors. Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774 [TBL] [Abstract][Full Text] [Related]
25. The role of residues in binding loop A in desflurane and propofol modulation of recombinant 5-HT3A receptor. Koo BN; Kim MK; Yang J; Min KT Neurosci Lett; 2009 Nov; 465(2):147-50. PubMed ID: 19765401 [TBL] [Abstract][Full Text] [Related]
26. Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response. Blier P J Psychiatry Neurosci; 2001; 26 Suppl(Suppl):S3-10. PubMed ID: 11590967 [TBL] [Abstract][Full Text] [Related]
27. Microarray analysis in drug discovery: an uplifting view of depression. Levy SE Sci STKE; 2003 Oct; 2003(206):pe46. PubMed ID: 14583588 [TBL] [Abstract][Full Text] [Related]
29. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Ressler KJ; Nemeroff CB Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410 [TBL] [Abstract][Full Text] [Related]
30. 5HT3 receptors: Target for new antidepressant drugs. Gupta D; Prabhakar V; Radhakrishnan M Neurosci Biobehav Rev; 2016 May; 64():311-25. PubMed ID: 26976353 [TBL] [Abstract][Full Text] [Related]
31. Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response. Dremencov E; Weizmann Y; Kinor N; Gispan-Herman I; Yadid G Curr Drug Targets; 2006 Feb; 7(2):165-75. PubMed ID: 16475958 [TBL] [Abstract][Full Text] [Related]
33. Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: a reciprocal risk factor for depression and insulin resistance? Pomytkin IA; Cline BH; Anthony DC; Steinbusch HW; Lesch KP; Strekalova T Behav Brain Res; 2015 Jan; 276():111-7. PubMed ID: 24815315 [TBL] [Abstract][Full Text] [Related]
34. Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models. Renoir T; Pang TY; Lanfumey L Neurosci Biobehav Rev; 2012 Jan; 36(1):696-726. PubMed ID: 22037449 [TBL] [Abstract][Full Text] [Related]
35. Local injections of serotonin type-3 receptor antagonists as a therapeutic option in rheumatology. Seidel MF Future Med Chem; 2012 Apr; 4(6):705-7. PubMed ID: 22530634 [No Abstract] [Full Text] [Related]
36. Diabetes-associated depression: the serotonergic system as a novel multifunctional target. Prabhakar V; Gupta D; Kanade P; Radhakrishnan M Indian J Pharmacol; 2015; 47(1):4-10. PubMed ID: 25821303 [TBL] [Abstract][Full Text] [Related]
37. The neurobiology of the EEG biomarker as a predictor of treatment response in depression. Baskaran A; Milev R; McIntyre RS Neuropharmacology; 2012 Sep; 63(4):507-13. PubMed ID: 22569197 [TBL] [Abstract][Full Text] [Related]